AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 2079: The Eliminating the Provider Relief Fund Tax Penalties Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| FREDERICK ESSIS | — |
Health Issues HCR
S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act S.1692/H.R.3354: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 H.R. 5657: Medical Marijuana Research Act Supporting vaccine requirements for health care workers. Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding the CDC National Neurological Conditions Surveillance System. Medical research funding related to fetal tissue, AHRQ, Congressionally Directed Medical Research Programs at the Department of Defense, and the NIH including the BRAIN Initiative. Support for funding for the Pediatric Subspecialty Loan Repayment Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| FREDERICK ESSIS | — |
| MAX GOLDMAN | — |
Veterans VET
Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
Medicare/Medicaid MMM
S. 368/ H.R. 1332: Telehealth Modernization Act S. 754/ H.R. 1916: Ensuring Lasting Smiles Act S. 833/ H.R. 2071: Empowering Medicare Seniors to Negotiate Drug Prices Act S. 1512/ H.R. 2903: CONNECT for Health Act of 2021 S. 1988/H.R. 5425: Protecting Rural Telehealth Access Act H.R. 366: Protecting Access to Post-COVID-19 Telehealth Act H.R. 3173: Improving Seniors Timely Access to Care Act H.R. 3447: Permanency for Audio-Only Telehealth Act H.R. 4040: Advancing Telehealth Beyond Covid-19 Act S. 610: Protecting Medicare and American Farmers from Sequester Cuts Act S. 1731: Medicare Audiologist Access and Services Act Engagement with CMS regarding National Coverage Analysis (NCA) of Aduhelm and other monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease Support for the elimination of the Medicare Appropriate Use Criteria (AUC) Program for advanced diagnostic imaging. Support for policies to address the COVID-19 pandemic, including extending temporary relief for Medicare Physician Fee Schedule payments and postponing Medicare sequestration cuts beyond 2021. Support for a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| FREDERICK ESSIS | — |
| MAX GOLDMAN | — |
Insurance INS
S. 464/ H.R. 2163: Safe Step Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEREK CHRISTOPHER BRANDT | — |
| FREDERICK ESSIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.